Skip to main content
main-content

27.04.2016 | Onlineartikel

Kandidaten Kategorie Forschungsleistung

 

 

Name

 

FirmaArbeiten
Priv.Doz. Dr. Michael PotenteMax-Planck-Institut für Herz- und Lungenforschung

FOXO1 couples metabolic activity and growth state in the vascular endothelium

Prof. Dr. Matthias Gunzer

 Universität Duisburg-Essen

Institut für Experimentelle Immunologie und Bildgebung 

ImmunoPET/MR imaging allows specific detection of Aspergillus fumigatus lung infection in vivo

Prof. Dr. Michael Soyka

Privatklinik Meiringen, Schweiz

1) New developments in the management of opiod dependence: focus on sublingual buprenorphine-naloxone 2) Buprenorphine-Naloxane Treatment in Opioid Dependance and Risk of Liver Enzyme Elevation: Results from a 12-Month Observational Study

Prof. Klaus BrandenburgForschungszentrum BorstelLeibniz-Zentrum für Medizin und Biowissenschaften

1) Lipoproteins/peptides are sepsis-inducing toxins from bacteria that can beneutralized by synthetic anti-endotoxin peptides 2) Peptide 19-2.5 Inhibits Heparan Sulfate-Triggered Inflamation in Murine Cardiomyocytes Stimulated with Human Sepsis Serum

Prof. Tobias Schürholz

Universitätsklinikum der RWTH Aachen

Klinik für Operative Intensivmedizin und Intermediate Care

1) Lipoproteins/peptides are sepsis-inducing toxins from bacteria that can beneutralized by synthetic anti-endotoxin peptides 2) Peptide 19-2.5 Inhibits Heparan Sulfate-Triggered Inflamation in Murine Cardiomyocytes Stimulated with Human Sepsis Serum

Dr. Janika Viereck und Prof. Dr. Thomas Thum

Medizinische Hochschule Hannover

Molekulare und Translationale Therapiestrategien

Long noncoding RNA Chast promotes cardiac remodeling